Procter & Gamble Officer Exercises and Sells $3.09M in Stock Options
PROCTER & GAMBLE Co
Subscribe to track PG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Insider Trade Alert: PROCTER & GAMBLE Co ($PG) Insider: Aguilar Moses Victor Javier (Chf Rsch, Dev & Innov Officer) Transaction Date: 2026-10-30 | Filing Date: 2026-11-03
Action: Option Exercise & Sale ⢠Shares Sold: 18,812 @ $164.43 (Total Value: $3,093,336.17) ⢠Shares Exercised: 18,812 @ $78.52 ⢠Direct Shares Remaining: 55,243.09 ⢠Indirect Shares Held: 7,974.74
Significance: Low (Routine option exercise and same-day liquidation)
Comprehensive Analysis
Executive Summary
On October 30, 2026, Victor Javier Aguilar Moses, Chief Research, Development & Innovation Officer of Procter & Gamble Co ($PG), completed an option exercise and same-day disposition involving 18,812 shares of Common Stock.
Transaction Breakdown
-
Option Exercise (Code M):
- Exercised employee stock options for 18,812 shares at a strike price of $78.52 per share.
- The options carried an original expiration date of February 28, 2028.
-
Open Market Sale (Code S):
- Concurrently sold all 18,812 exercised shares at a volume-weighted average price of $164.4342 (price range: $164.39 to $164.515).
- Total gross proceeds amounted to approximately $3,093,336.17.
- Net pre-tax gain realized from the spread was approximately $1,616,211.
Holdings Analysis
- Direct Ownership After Transaction: 55,243.0935 shares.
- Indirect Ownership:
- 7,546.1382 shares held through the Retirement Plan Trustee.
- 428.6033 shares held via the International Stock Ownership Plan (Mexico) Trustee.
- Net Change in Base Equity: Because the number of shares sold equaled the number of option shares exercised, the executive's core holding of directly owned shares remained unchanged.
Assessment
This transaction represents standard executive compensation realization via an exercise-and-sell transaction. Given that the insider's baseline share count was preserved and the options were exercised well ahead of their 2028 expiration date, the trading significance is evaluated as Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
